| Acquired immunity to malaria DL Doolan, C Dobaņo, JK Baird Clinical microbiology reviews 22 (1), 13-36, 2009 | 1432 | 2009 |
| Global technical strategy for malaria 2016-2030 World Health Organization World Health Organization, 2015 | 912 | 2015 |
| Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite I Mueller, MR Galinski, JK Baird, JM Carlton, DK Kochar, PL Alonso, ... The Lancet infectious diseases 9 (9), 555-566, 2009 | 761 | 2009 |
| A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010 PW Gething, IRF Elyazar, CL Moyes, DL Smith, KE Battle, CA Guerra, ... Public Library of Science 6 (9), e1814, 2012 | 653 | 2012 |
| The International Limits and Population at Risk of Plasmodium vivax Transmission in 2009 CA Guerra, RE Howes, AP Patil, PW Gething, TP Van Boeckel, ... PLoS neglected tropical diseases 4 (8), e774, 2010 | 580 | 2010 |
| Primaquine therapy for malaria JK Baird, SL Hoffman Clinical infectious diseases 39 (9), 1336-1345, 2004 | 537 | 2004 |
| G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map RE Howes, FB Piel, AP Patil, OA Nyangiri, PW Gething, M Dewi, ... PLoS medicine 9 (11), e1001339, 2012 | 504 | 2012 |
| Effectiveness of antimalarial drugs JK Baird New England Journal of Medicine 352 (15), 1565-1577, 2005 | 481 | 2005 |
| Global epidemiology of Plasmodium vivax RE Howes, KE Battle, KN Mendis, DL Smith, RE Cibulskis, JK Baird, ... The American journal of tropical medicine and hygiene 95 (6 Suppl), 15, 2016 | 417 | 2016 |
| Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I DR Hill, JK Baird, ME Parise, LS Lewis, ET Ryan, AJ Magill | 415 | 2006 |
| Evidence and implications of mortality associated with acute Plasmodium vivax malaria JK Baird Clinical microbiology reviews 26 (1), 36-57, 2013 | 405 | 2013 |
| Chloroquine Resistance in Plasmodium vivax JK Baird Antimicrobial agents and chemotherapy 48 (11), 4075-4083, 2004 | 384 | 2004 |
| Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis RN Price, L Von Seidlein, N Valecha, F Nosten, JK Baird, NJ White The Lancet infectious diseases 14 (10), 982-991, 2014 | 368 | 2014 |
| Host age as a determinant of naturally acquired immunity to Plasmodium falciparum JK Baird Parasitology today 11 (3), 105-111, 1995 | 368 | 1995 |
| Resistance to Therapies for Infection by Plasmodium vivax JK Baird Clinical microbiology reviews 22 (3), 508-534, 2009 | 325 | 2009 |
| Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination TNC Wells, JN Burrows, JK Baird Trends in parasitology 26 (3), 145-151, 2010 | 324 | 2010 |
| Neglect of Plasmodium vivax malaria JK Baird Trends in parasitology 23 (11), 533-539, 2007 | 323 | 2007 |
| Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study KE Battle, TCD Lucas, M Nguyen, RE Howes, AK Nandi, KA Twohig, ... The Lancet 394 (10195), 332-343, 2019 | 275 | 2019 |
| Geographical variation in Plasmodium vivax relapse KE Battle, MS Karhunen, S Bhatt, PW Gething, RE Howes, N Golding, ... Malaria journal 13 (1), 1-16, 2014 | 266 | 2014 |
| Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. JK Baird, H Basri, MJ Bangs, B Subianto, LC Patchen, SL Hoffman The American journal of tropical medicine and hygiene 44 (5), 547-552, 1991 | 266 | 1991 |
